ORIGINAL ARTICLES
Cardiovascular
risk factor prevalence among men in a
large industry of northern India
D. Prabhakaran, Pankaj Shah, Vivek Chaturvedi, Lakshmy
Ramakrishnan, Ajay Manhapra, K. Srinath Reddy
ABSTRACT
Background.Industrial
settings, with their intramural resources and healthcare
infrastructure, are ideal for
initiating preventive activities to increase the awareness
and control of cardiovascular diseases (CVD). However,
there are no reliable estimates of CVD and risk factor
burden, nor of its awareness and treatment status in urban
Indian industrial settings. We aimed to evaluate the prevalence
of CVD and its risk factors, and to assess the status of
awareness and control of CVD risk factors among a large
industrial population of northern India.
Methods.We conducted
a cross-sectional survey among all employees aged 20–59
years of a large industry near Delhi (n=2935), to evaluate
their cardiovascular risk profile—by
employing a structured questionnaire and clinical and biochemical
estimations. The presence of coronary heart disease was
ascertained by evidence of its treatment, Rose angina questionnaire
and Minnesota coded electrocardiograms.
Results.The
results for 2122 men, in whom complete information was
available, are reported here. The mean age was 42 years
and 90% of the men were below 50 years of age. The prevalence
of major CVD risk factors (95% CI) was: hypertension 30%
(28%–32%), diabetes 15% (14%–17%), high serum
total cholesterol/HDL ratio (>4.5) 62% (60%–64%)
and current smoking 36% (34%–38%). Forty-seven per
cent of the respondents had at least two of these risk
factors. Another 44% (95% CI: 42%–46%) had pre-hypertension
(JNC VII criteria) and 37% (95% CI: 35%–39%) had
evidence of either impaired fasting glucose or impaired
glucose tolerance. Thirty-five per cent (95% CI: 33%–37%)
of the individuals were overweight (BMI >25 kg/m2) while
43% (95% CI: 40%–45%) had central obesity (waist
circumference >90 cm). The metabolic syndrome was present
in 28%–35% of the individuals depending on the diagnostic
criteria used. The prevalence of several risk factors and
the metabolic syndrome was high with increasing age, BMI
and waist circumference. A third of those who had hypertension
(31.5%) and diabetes (31%) were aware of their status.
Among those aware, adequate control of blood pressure and
blood glucose was present in only 38% of those with hypertension
and 31% of those with diabetes, respectively. Coronary
heart disease was present in 7.3% of the individuals while
0.3% had a history of stroke.
Conclusion.This
study demonstrates the high prevalence of CVD and its risk
factors against a background of poor
awareness and control among a comparatively young male
population in a north Indian industrial setting.
Natl Med J India 2005;18:59–65
INTRODUCTION
The cardiovascular disease (CVD) burden of India is expected
to double in the next two decades, making it the single
largest cause of death and the second largest cause of
disability by the year 2020.1 This
will be characterized by an enormous burden of CVD among
urban communities.
Further, the prevalence of CVD in rural and semi-urban
areas is expected to increase substantially.2,3 While
the exact aetiology of this predisposition to CVD in
Indians is still debated, from a public health point
of view it is clear that the rapid transition in diet
and lifestyles with urbanization has contributed to increasing
levels of potentially reversible CVD risk factors.4 Data
from several cross-sectional studies confirm the high
prevalence of risk factors such as smoking, type 2 diabetes,
high blood pressure, dyslipidaemia and obesity5–11 in
urban Indians. Despite this high burden, there is poor
awareness among Indians, in addition to low detection
and control rates.12–18 The
reasons for this include low literacy, lack of access
to healthcare and competing
priorities such as infectious and nutritional diseases.
Given this background and with the expected overall improvement
in literacy and socioeconomic status, it would be useful
to study the awareness of CVD risk factors and lifestyle
patterns in industrial settings, where the access to
healthcare is usually better than that among the general
community.
Recent
research has highlighted the importance of a continuum
of risk with variables such as blood pressure and glucose.19–23 There
is robust evidence of increased vascular risk even in the
presence of pre-hypertension (or high-normal blood
pressure) and pre-diabetes (impaired fasting glucose and
impaired glucose tolerance).24,25 These
risk categories have a high rate of progression to hypertension
and type
2 diabetes. They are also components of the metabolic syndrome,
which confers an almost 2-fold risk for future diabetes,
CVD mortality and morbidity.26,27 However,
detailed data regarding the burden of these risk factors
in India are
limited.
We
report the findings of a survey done among the employees
of a large organized sector industry located close to Delhi.
The main objectives of the study were (i) to study the
risk factor and treatment status in individuals with respect
to CVD, (ii) to estimate the prevalence of risk factors
for coronary heart disease (CHD), both traditional and
intermediary, and (iii) to estimate the prevalence of CHD
using a history of previously diagnosed disease, Rose angina
questionnaire and electrocardiogram (ECG).
METHODS
Study design and setting
We did a cross-sectional survey of all employees in the
20–59 years’ age group in an organized sector
industry, during 1995–98. A total of 2935 employees
(344 women and 2591 men) were eligible to participate.
All potential participants received a letter inviting them
to participate in the study. Approval for conducting the
study was obtained both from the management and the employee
representatives. Participation in the study was voluntary
and all the measurements were carried out in the medical
unit located within the industry. Informed consent was
obtained from each participant.
Study questionnaire
We used a simple structured questionnaire which was administered
by research assistants, who had received training in the
methodology of field-based cardiovascular surveys. The
questionnaire was used to elicit information from each
study participant for the following variables: (i) demographic
characteristics such as age, marital status, profession,
education and socioeconomic status; (ii) lifestyle-related
factors such as dietary habits, physical activity, tobacco
and alcohol consumption; (iii) the health status of the
individual and any history related to heart disease, stroke,
hypertension and diabetes. The presence of angina was assessed
using the Rose angina questionnaire. If a person reported
the presence of hypertension or diabetes or CVD (defined
as the presence of CHD or stroke or angina), a detailed
questionnaire was administered to elicit information on
control, awareness, treatment and limitations due to the
illness. Each question was structured to gather as much
information as possible without increasing the duration
of the interview, which usually lasted about 30 minutes.
Clinical measurements and anthropometry
A 30 second pulse rate was measured in each individual
followed by 2 blood pressure measurements using a random
zero sphygmomanometer by standard techniques.28 The
measurements were obtained half an hour apart, either before
or 1 hour
after the first blood sampling. The lower of the two measurements
was used for this analysis. Height was measured in centimetres
using a stadiometer, which was calibrated to the nearest
0.5 cm, and weight was measured using a bathroom scale,
which was validated on a daily basis with known weights.
Waist
and hip circumferences were measured in the following manner.
The subject was asked to stand with the arms by
the sides and to breathe normally. The following points
were marked on the right side: (i) the subcostal margin
in the mid-axillary line, (ii) the highest point of the
iliac crest in the mid-axillary line. The centre of these
two points was marked. At this point the waist circumference
was measured with a fibreglass tape after applying a tension
of 600 g (done with the help of a spring balance). The
measurement was made up to the nearest millimetre. Adequate
care was taken to ensure that the subject was breathing
normally at the time the measurement was taken. Hip circumference
was measured at the level of the greater trochanters with
the subject standing and breathing normally in a manner
similar to that during measurement of the waist circumference.
All the measurements were taken without intervening clothes,
with the subject wearing a loose-fitting surgical gown.
An
ECG was obtained after the clinical measurements. All ECGs
were read by a cardiologist and coded using the Minnesota
coding system. Ten per cent of randomly selected ECGs were
checked by two different cardiologists for agreement. There
was complete agreement between the original and fresh coding.
(Kappa was not estimated in view of the complete agreement.)
Laboratory measurements
Blood samples were drawn by trained personnel, centrifuged
and stored for later analysis. Laboratory measurements
included estimation of fasting blood glucose, 2-hour post-load
blood glucose (all post-load measurements were made 2 hours
after a 75 g glucose solution was administered orally under
supervision), plasma insulin (both fasting and post-load),
total blood cholesterol, high density lipoprotein (HDL)
cholesterol (HDL-C), and triglycerides (both fasting and
post-load). Glucose was analysed by the glucose oxidase
method (GOD-PAP), cholesterol by the CHOD-PAP method, and
triglycerides were estimated by the GPOD-PAP method. The
intra- and interassay coefficient of variation (CV) for
glucose was 1.5% and 2%, respectively; for cholesterol
and triglycerides these were <2% and <2.5%, respectively.
HDL-C was estimated by the precipitation method (phosphotungstate/Mg)
and the inter- and intra-assay CVs were <2.5%. Insulin
concentrations were measured by radioimmunoassay (Coat-a-Count
insulin kit, Diagnostic Products). The intra- and interassay
CVs were <5% and <7.5%, respectively.
Definition of risk factors
The definitions used for the categorization of risk levels
among the participants are given in Box 1.
Statistical analysis
Statistical analysis was performed using the SPSS Version
9.0 package. Continuous data are summarized as means and
standard deviations and categorical data as proportions.
We used the Student t test for comparing means and a chi-square
test for categorical variables.
RESULTS
Of the 2935 eligible individuals (11.7% women), 2548 (86.8%
of total, 266 women and 2282 men) agreed to participate
in the study. We report here the results of the men, as
the number of women who were eligible and participated
in the study was small (10.4%). Of the 2282 men, 14 declined
to undergo clinical examination or give blood samples.
Complete data for all the risk variables were available
for 2122 subjects.
Demographic characteristics
The mean age of the participants was 42 years. Nearly 60%
of the participants were in the 41–50 years’ age
group (Table I). A large
Box 1. Definitions for different risk factors in
the study
Hypertension: Systolic blood pressure (BP) >139
mmHg or diastolic BP >89 mmHg or history of
treatment for hypertension
Pre-hypertension: Systolic BP of 120–139 mmHg
or diastolic BP of 80–89 mmHg in non-hypertensive
subjects
Diabetes: Fasting blood glucose >126 mg/dl or 2-hour
post-load blood glucose >200 mg/dl or history
of treatment for diabetes
Impaired fasting glucose: Fasting blood glucose >100
mg/dl and <126 mg/dl, in the non-diabetic population
Impaired glucose tolerance: Fasting glucose <126
mg/dl and 2-hour post-load blood glucose of 140–199
mg/dl in the non-diabetic population
Tobacco use: Consumption of any form of tobacco in
the past 6 months. The types of tobacco consumption
considered included smoked (cigarettes, beedis and
cigars), oral (tobacco chewed, pan masala, etc.) and
inhaled forms (snuff)
Hypercholesterolaemia: Total blood cholesterol
levels >200
mg/dl
Hypertriglyceridaemia: Fasting serum triglyceride
levels >150
mg/dl
Decreased high density lipoprotein cholesterol:
Fasting blood HDL-cholesterol <40 mg/dl
Adverse total cholesterol/high density lipoprotein
cholesterol ratio: ³4.5
Overweight: Body mass index* ³25 kg/m2
Central obesity: Among men a waist circumference
of >94
cm (as per the NCEP-ATP III guidelines for genetically
high risk men) or a waist–hip ratio >0.90
as per the WHO criteria indicated central obesity
Coronary heart disease (CHD): A positive history
of CHD or presence of ECG abnormalities 1-1-1,
1-1-2, 1-1-3, 1-1-4, 1-1-5, 1-1-6 and 1-1-7 representing
major
Q waves; 4-1-1 and 4-1-2 representing ST–T
changes and 5-1 and 5-2 representing T wave changes
in the
Minnesota coding system
Metabolic syndrome:
NCEP-ATP III criteria:32 For men, presence of >3 of the following: fasting
plasma glucose levels >110 mg/dl, serum triglycerides >150 mg/dl, serum
high density lipoprotein cholesterol <40 mg/dl, blood pressure >130/85
mmHg, and waist girth >102 cm. Use of waist circumference >94 cm suggested
for men who might be genetically susceptible to insulin resistance
WHO criteria:33 For men, insulin resistance in the top 25% of the population
as measured by the euglycaemic–hyperinsulinaemic clamp method or the presence
of impaired glucose tolerance or type 2 diabetes, and the presence of at least
2 of the following: abdominal obesity (waist–hip ratio >0.90 or body
mass index >30 kg/m2), dyslipidaemia (serum triglycerides >150 mg/dl) or
high density lipoprotein cholesterol <35 mg/dl, hypertension (>160/90
mmHg), or microalbuminuria
*BMI is obtained by dividing the weight in kilograms by the square of the
height in metres. Recent data suggest that this cut-off possibly underestimates
obesity
in Asians and hence we also report overweight using the cut-off of BMI ³23
kg/m2
NCEP-ATP III National Cholesterol Education Program Adult Treatment Panel III |
majority were
educated with 66.4% having graduate, postgraduate or professional
qualifications. Twenty-one per cent had secondary level
education and the remaining 12.6% were illiterate (Table
I). The majority of employees were either skilled workers
(47%) or professionals (26%). Semi-skilled and unskilled
workers constituted 14% and 2.4% of the workforce, respectively.
The remaining were clerical staff (11.5%).
Table I. Baseline characteristics of the study population
(n=2122) |
Characteristic |
Percentage |
Age group (years) |
|
21–30 |
5.5 |
31–40 |
25.4 |
41–50 |
59.2 |
51–59 |
9.8 |
Educational achievements |
|
No education or some education* |
12.6 |
Secondary school |
21 |
Graduate/postgraduate/professional |
66.4 |
|
|
Clinical, laboratory, and anthropometric measurements |
Mean (SD) |
Mean age (years) |
42 (6.5) |
Systolic blood pressure (mmHg) |
122 (13.3) |
Diastolic blood pressure (mmHg) |
83 (9.5) |
Fasting blood glucose (mg/dl) |
101 (32.6) |
Fasting serum insulin (IU/L)† |
9.4 (16.7) |
log insulin† |
1.7 (0.8) |
Total blood cholesterol (mg/dl) |
180.5 (45.5) |
Low density lipoprotein cholesterol (mg/dl) |
114.4 (43.5) |
High density lipoprotein cholesterol (mg/dl) |
36.4 (9.7) |
Serum fasting triglycerides (mg/dl) |
149 (95) |
Total/high density lipoprotein cholesterol ratio |
5.3 (1.9) |
Body mass index (kg/m2) |
23.7 (3.4) |
Waist circumference (cm) |
87.6 (10.3) |
Waist–hip ratio |
0.97 (0.06) |
*primary education †30 missing values, n=1812 |
|
Risk factors
The mean values of various clinical, laboratory and anthropometric
measurements are given in Table I. The age-stratified
and total prevalence of CVD risk factors are given in
Table
II. Normal blood pressure (systolic pressure <120 mmHg
and diastolic pressure <80 mmHg, respectively) was observed
in a quarter (25.6%) of the individuals surveyed. The prevalence
of pre-hypertension and hypertension as per the Seventh
Joint National Committee (JNC VII) criteria was 44% (95%
CI: 42%–47%) and 30% (95% CI: 28%–32%), respectively.
Among those with hypertension only one-third (31.5%) were
aware of their blood pressure status. Of these, only 38%
(12% of the total who were hypertensive) had their blood
pressure under control (<140/90 mmHg). The proportion
of individuals with hypertension who were aware of their
disease increased with age (from 19% of all those with
hypertension in the 20–29 years’ age group
to 40.5% in the 50–59 years’ age group). Diabetes
was present in 15% (95% CI: 14%–17%) and another
30.7% (95% CI: 29%–33%) had evidence of abnormal
glucose homeostasis, denoted by impaired fasting glucose.
Impaired glucose tolerance, an indicator of insulin resistance,
was observed in 13.2% (95% CI: 12%–15%) of participating
individuals (Table II). While 31% of those with diabetes
were aware of their status, in only 17% of these (5% of
the people with diabetes) was the blood glucose controlled
to normoglycaemic levels (fasting plasma glucose <100
mg/dl and postprandial glucose <140 mg/dl)). The proportion
of individuals with diabetes who were aware of their disease
increased with age (from 20% of all those with diabetes
in the 20–29 years’ age group to 42.1% in the
50–59 years’ age group).
Table II. Overall and age-stratified
prevalence (%) of risk factors |
Risk factor |
Total (95% CI) |
Age group (in years) |
21–30 |
31–40 |
41–50 |
51–59 |
Hypertension |
30 (28–32) |
18.1 |
21 |
33.2 |
40.2 |
Pre-hypertension |
44 (42–46) |
55.2 |
55.1 |
41.7 |
40.2 |
Normal blood pressure |
25.6 |
26.7 |
28.9 |
25.1 |
19.6 |
Diabetes |
15 (14–17) |
4.3 |
10.4 |
17.6 |
18.3 |
Normal glucose tolerance (fasting glucose <100
mg/dl) |
48.1 |
52.2 |
50.2 |
47.0 |
46.6 |
Isolated impaired fasting glucose* (IFG) |
23.6 |
34.8 |
25.0 |
22.1 |
22.6 |
Isolated impaired glucose tolerance† (IGT) |
6.1 |
3.5 |
8.3 |
5.6 |
4.8 |
IFG and IGT combined |
7.2 |
5.2 |
6.1 |
7.7 |
7.7 |
IFG or IGT |
37 (35–39) |
43.5 |
39.4 |
35.4 |
35.1 |
Total cholesterol |
|
|
|
|
|
>200 mg/dl |
30.1 (28–32 |
21.6 |
29.6 |
30.9 |
31.1 |
>240 mg/dl |
9.8 (8.5–11) |
6
|
9.6 |
10.3 |
9.6 |
Low density lipoprotein cholesterol |
|
|
|
|
|
>130 mg/dl |
33 (31–35) |
26 |
33 |
34 |
31.6 |
>160 mg/dl |
13.6 (12–15) |
9.5 |
14 |
14 |
13.4 |
High density lipoprotein cholesterol |
67.2 (65–69) |
66.4 |
69.1 |
67.1 |
63.2 |
Total/high density lipoprotein cholesterol ratio ³4.5 |
62 (60–64) |
53.4 |
60 |
64.1 |
56.5 |
Fasting triglycerides |
|
|
|
|
|
>150 mg/dl |
38 (38–42) |
19.8 |
36.1 |
38.9 |
46.4 |
>200 mg/dl |
19.9 (18–22) |
12.1 |
17.4 |
21.4 |
21.5 |
Tobacco use |
48.3 |
|
|
|
|
Current tobacco smoking |
36 (34–38) |
15.5 |
35.6 |
37.0 |
41.1 |
Overweight (BMI ³25 kg/m2) |
35 (33–37) |
18.1 |
29.1 |
37.2 |
44.5 |
Obese (BMI ³30 kg/m2) |
3.3 (2.6–4.1) |
0 |
24 |
4.0 |
3.8 |
BMI ³23 kg/m2 |
58.5 (56.4–60.6) |
0 |
|
|
|
Central obesity (waist circumference >102 cm) |
7.2 (6.0–8.3) |
0 |
4.6 |
7.9 |
13.4 |
Waist circumference |
|
|
|
|
|
>94 cm |
26.5 (25–28) |
5.2 |
18.1 |
29.9 |
39.7 |
>90 cm |
43 (40–45) |
10.3 |
32.2 |
47.7 |
56.5 |
Waist–hip ratio |
|
|
|
|
|
³0.95 |
66.6 (64.6–68.6) |
28.4 |
54.6 |
73.4 |
77.5 |
³0.90 |
88.7 (87.3–90.0) |
66.4 |
84.1 |
92.0 |
93.3 |
Presence of ³2 major risk factors‡ |
47 |
23.5 |
39 |
51.3 |
51.4 |
CI confidence interval BMI body mass
index * after excluding IGT from the analysis † after
excluding IFG from the analysis
‡
hypertension, diabetes, current smoking, and total/high
density lipoprotein cholesterol ratio ³4.5
|
Hypercholesterolaemia (total cholesterol ³200 mg/dl)
was observed in 30.1% (95% CI: 28%–32%) of individuals,
and hypertriglyceridaemia (serum fasting triglycerides ³150
mg/dl) in 38% (95% CI: 38%–42%) of those surveyed
(Table II). A large proportion (67.2% [95% CI: 65%–69%])
of individuals had low HDL-C levels (serum HDL-C <40
mg/dl), which resulted in nearly two-thirds (62%) of individuals
having a total cholesterol/HDL-C ratio of ³4.5.
Overall, this population had a high rate of tobacco
use (48.3%);
36% of the individuals were current smokers (cigarettes
21.5% and beedis 19.7%), and one-quarter of the population
used non-smoking forms (Table II). The commonest non-smoking
form of tobacco use was chewing tobacco or pan masala
mixed with tobacco.
One-third of the population (35% [95% CI: 33%–37%])
was overweight using the traditional cut-off of BMI ³25
kg/m2. However, as per the recent WHO recommendations for
defining health risks associated with BMI in Asians, 12.2%
were in the ‘high to very high’ risk (BMI ³27.5
kg/m2) category and 58.5% in the ‘moderate to high
risk’ (BMI ³23 kg/m2) category29 (Table
II). Similarly, very few individuals were centrally
obese by
the National Cholesterol Education Program (NCEP) criteria
of waist circumference >102 cm (7.2%). However, 43%
(95% CI: 40%–45%) of the individuals had a waist
circumference ³90 cm, the proposed criteria for central
obesity in men in the Asia-Pacific region,30 while
26.5% (95% CI: 25%–28%) had a waist circumference >94
cm, the proposed first action level in the Caucasian
population.31
Table III. Prevalence (%) of the metabolic syndrome
(n=2120) |
Criteria for metabolic syndrome |
Total |
Age group (in years) |
21–30 |
31–40 |
41–50 |
51–59 |
NCEP criteria |
28.1 |
12.9 |
23.4 |
29.8 |
38.3 |
NCEP modified criteria* |
35.3 |
14.7 |
29 |
37.9 |
47.8 |
Modified WHO criteria† |
29 |
16.4 |
25.8 |
30.6 |
34.6 |
NCEP National Cholesterol Education Programme
* Waist circumference >94 cm (in genetically susceptible
populations); other criteria are the same
†
Revised definition of WHO metabolic syndrome: microalbuminuria
not included as a criterion; blood pressure (BP) thresholds
for defining hypertension taken as systolic BP ³140
mmHg and diastolic BP ³90 mmHg; dysglycaemia defined
as presence of diabetes or impaired fasting glucose
or impaired glucose tolerance (insulin parameters not
used) |
The
metabolic syndrome was present in 28.1% (95% CI: 26%–30%)
of the study population (Table III) by the NCEP Adult Treatment
Panel (ATP) III criteria (see Box 1).32 Using
the criteria for genetically susceptible populations
(waist circumference >94
cm instead of 102 cm), the prevalence of the metabolic
syndrome was higher (35%). Using the modified WHO criteria33 for
defining the metabolic syndrome (see Box 1 and Table
III), the prevalence was 29% (95% CI: 27%–31%). The
prevalence of the metabolic syndrome using the modified
NCEP definition was 29% after individuals with diabetes
were excluded, and 21.7% when only individuals with normoglycaemia
were considered. Among 1798 individuals without diabetes,
fasting serum insulin levels were available for 1552 persons.
The mean and median values of insulin were 8.8 IU/L and
5.0 IU/L, respectively. After log transformation of insulin
values to make the distribution normal, the mean values
of insulin were consistently higher in those with the metabolic
syndrome as compared to those without (1.9 and 1.67, respectively,
among those with and without the metabolic syndrome, p
for difference <0.001) irrespective of the way the
metabolic syndrome was defined.
Only 15% of the study population were free from any
of the risk factors (hypertension, diabetes, current
smoking
and total cholesterol/HDL-C ratio ³4.5). While
85% of the study population had at least 1 of these
risk factors,
about 47% of the employees had at least 2 co-existing
risk factors.
Effect of age on CVD risk factors
While diabetes, hypertension, hypertriglyceridaemia,
overweight, central obesity and the metabolic syndrome,
as well as
the presence of multiple risk factors showed rising
trends with age, the prevalence of smoking, low HDL
and adverse
total cholesterol/HDL-C ratio was roughly similar in
all the age groups (Table II). Even the youngest age
group
of 20–29 years had a high prevalence of risk
factors such as dyslipidaemia, hypertension and diabetes.
Effect of adiposity on CVD risk factors
There was a continuous graded increase in mean values
as well as risk factor prevalence with increasing BMI
(Fig.
1) and waist circumference (Fig. 2). The risk of developing
obesity-associated risk factors started to rise much
below the defined thresholds for western populations
(BMI >25
kg/m2 and waist circumference >94 cm).
Prevalence of CVD
|
Fig 1. Prevalence of risk factors in the four quartiles
of body mass index (all values in kg/m2)
Quartile I: 13.9–21.2; Quartile II: 21.3–23.7;
Quartile III: 23.8–25.8; Quartile IV: 25.9–37.2
*TC:HDL ratio total cholesterol:high density lipoprotein
cholesterol ratio
† Metabolic syndrome as defined by the NCEP-ATP III but
excluding waist circumference from the definition |
|
Fig 2. Prevalence of risk factors in the four quartiles
of waist circumference (all values in cm)
Quartile I: 51.4–81.0; Quartile II: 81.1–88.0;
Quartile III: 88.1–94.5; Quartile IV: 94.6–131
*TC:HDL ratio total cholesterol:high density lipoprotein
cholesterol ratio
†
Metabolic syndrome as defined by the NCEP-ATP III but
excluding waist circumference from the definition |
A
past history of diagnosed CHD and stroke was identified
in 16 (0.8%) and 7 (0.3%)
individuals, respectively.
The prevalence of CHD, defined as history of CHD (identified
by the modified Rose questionnaire) or presence of
ECG abnormalities suggestive of CHD (by specified Minnesota
codes), was noted in 7.3% of men. Abnormal ECGs suggestive
of CHD in the form of Q waves, T wave and ST–T
abnormalities were observed in 2.5% of the population
studied.
DISCUSSION
Our study on the cardiovascular risk profile in a industrial
workplace setting in India, among a relatively young
urban population, found the prevalence of traditional
risk factors
to be high. Even in the 20–29 years’ age group,
only one-quarter of the individuals had normal blood pressure,
only half had normal glucose tolerance, more than half
had dyslipidaemia, one-fifth were overweight, and more
than one-fifth had at least 2 major risk factors. Awareness
and control of hypertension and diabetes was poor, indicating
low detection and poor management of major CVD risk factors.
The high prevalence of ‘risk markers’ such
as impaired fasting glucose and glucose tolerance,
and pre-hypertension suggests that there is a large
vulnerable
population which can develop an overt adverse risk
profile and CVD in the future.
Community-based cross-sectional surveys and other studies
carried out in the past few decades have revealed a
high and increasing prevalence of CVD and its risk
factors
in individuals of South Asian origin residing, in India
as
well as in other countries.5–11,34–37 However,
not many of these have evaluated the CVD risk profile
in
younger populations. The disconcertingly low level
of awareness of CVD and its treatment further increases
the risk for
future morbidity and mortality due to CVD. The low
awareness and control noted in our population is similar
to data
published from other developing countries such as China.
Tao et al.38 from their
nationwide survey of blood pressure of more than 950
000 men and women, found
that of all the
hypertensives, only 25% were aware of their hypertensive
status and, among those aware, only half were on any
blood pressure lowering medications. Overall, in only
3% was
the blood pressure controlled to normal levels, although
this had improved by 2000–01.39 Further,
a recent report highlights the urban–rural differences
in the awareness, treatment and control of hypertension.
The
Hypertension Study Group40 while
noting similar low rates of awareness and control,
identified visit to
a physician
in the previous 1 year, higher educational attainment
and female gender to be important correlates of awareness
among
a cross-section of subjects with hypertension from
India and Bangladesh. Therefore, while opportunistic
screening
may identify individuals with undetected hypertension
and diabetes, we need specific strategies to improve
the control
and therapy of those with CVD risk factors.
The importance of insulin resistance in determining
the high mortality due to CVD among Indians has been
highlighted
by McKeigue41 and Hughes.42 Based
largely on data obtained from migrant Indians and comparing
them to indigenous
populations, Indians were believed to have an enhanced
propensity to
insulin resistance and CVD.41 Though others have questioned
the role of insulin resistance and emphasized the importance
of conventional risk factors such as lipids, the high
prevalence of the metabolic syndrome and its association
with hyperinsulinaemia
indirectly underscores the importance of insulin resistance
among Indians. We explored the causes for the high
prevalence of the metabolic syndrome in our study population
and
found overweight and central obesity to be major correlates
of
these risk markers (Figs. 1 and 2). As there is a pronounced
urban–rural gradient in obesity among Asian Indians,43 we
believe that the high prevalence of risk markers such
as impaired glucose tolerance, the metabolic syndrome
and
high-normal blood pressure, all of which are influenced
by body fat, is a reflection of the current urbanization
and adaptation of a western lifestyle among the Indian
population. The prevention and management of the metabolic
syndrome largely involves lifestyle modifications.
Recently published clinical trials such as the Diabetes
Prevention
Programme44 and the Finnish
diabetes prevention studies45 have
established the importance of lifestyle measures
in the prevention of diabetes. Similarly, a low level
of physical
activity and a diet rich in saturated fats and high
glycaemic foods have been implicated in the pathogenesis
of the metabolic
syndrome.46
While such a high prevalence of risk factors is a cause
for concern, organized sector industries provide a
unique opportunity for carrying out prevention programmes.
It
is estimated that there are nearly 6 million people
working in such large organized sector industries in
India. While
most of these have their own primary healthcare facilities,
they also provide for the healthcare of employees and
their dependents in higher medical institutions when
required.
With the rising burden of CVD, the expenditure on such
healthcare programmes by every industry is likely to
increase enormously. Thus, there is a lot of scope
for and benefit
in initiating comprehensive, low-cost CVD prevention
programmes at the workplace for employees and their
dependants. Such
onsite programmes have been found to be modestly successful
in the West through increased awareness, health education
and risk reduction interventions, and modified models
could easily be adapted to Indian settings. This is
likely to
lead to a healthier workforce as well as a decrease
in expenditure by the industry on treatment costs and
increased
absenteeism. We hope that our study will provide the
stimulus for initiating such surveillance and preventive
activities.
The prevalence rates that we have reported are based
on western cut-offs and we require a longitudinal evaluation
of our study population on CVD morbidity and mortality
to fully understand the implications of our findings.
To
address the above issues, and to document changes in
risk factors and prospectively identify determinants
of CVD,
we are continuing our study in this industrial population.
Limitations
As the study was carried out in an industrial setting,
it may not be representative of the general population.
Though we have provided age-specific prevalence rates,
the industrial population is different from the general
population in terms of its socioeconomic profile. However,
this study is broadly generalizable to similar large,
organized sector workforce involving nearly 6 million
employees.
Further, our study population comprised predominantly
young men. Also, women comprised only 10% of the workforce.
The
results of this study cannot be generalized to individuals
older than 60 years, in whom the risk factor as well
as disease burden will be even higher than that reported
in
this population.
Conclusion
We have demonstrated a high prevalence of CVD risk
factors, its markers such as the metabolic syndrome
and risk determinants
such as obesity (both generalized and central) among
a group of young men. Though the study population was
not
representative of the national population (older, only
men, higher educational and socioeconomic strata),
we believe that it does represent the rising trend
of CVD
in urban
India. Despite the availability of onsite healthcare
and a high level of education as compared to the general
population,
the awareness and treatment of hypertension and diabetes
is low. Therefore, there is a pressing need to initiate
onsite preventive programmes to identify and manage
individuals at high risk for future CVD.
ACKNOWLEDGEMENTS
The International Clinical Epidemiology Network (INCLEN)
provided partial financial support for this study.
We gratefully acknowledge the cooperation of the employees
and the management of Bharat Electronics Limited for
participating in this study, Dr S. K. Puri and Dr Medha
Joshi for providing
clinical support at the industrial site, A. Karthika
for data management, and all the research and support
staff,
without whom this study would not have been possible.
REFERENCES
|
- Murray CJL, Lopez AD. Global health statistics:
Global burden of disease and injury series. Vols.
I and II. Boston:Harvard School of Public Health;
1992.
- Gupta R, Gupta VP. Meta-analysis of coronary
heart disease prevalence in India. Indian
Heart J 1996;48:241–5.
- Krishnaswami S, Joseph
G, Richard J. Demands on tertiary care
for cardiovascular diseases
in India: Analysis
of data for 1960–89. Bull World Health
Organ 1991;69: 325–30.
- Reddy KS, Yusuf
S. Emerging epidemic of cardiovascular disease
in developing countries. Circulation 1998;97:596–601.
- Chadha SL, Gopinath
N, Shekhawat S. Urban–rural
differences in the prevalence of coronary
heart disease and its risk factors in Delhi. Bull
World Health Organ 1997;75:31–8.
- Gupta R, Gupta VP, Sarna
M, Bhatnagar S, Thanvi J, Sharma V, et al.
Prevalence of coronary
heart
disease
and risk factors in an urban Indian population:
Jaipur Heart Watch-2. Indian Heart J 2002;54:59–66.
- Ramachandran A, Snehalatha C, Latha E, Satyavani
K, Vijay V. Clustering of cardiovascular risk
factors in urban Asian Indians. Diabetes
Care 1998;21:967–71.
- Joseph A, Kutty VR, Soman
CR. High risk for coronary heart disease in
Thiruvananthapuram
city: A study
of serum lipids and other risk factors. Indian
Heart J 2000;52:29–35.
- Misra A, Pandey RM, Devi
JR, Sharma R, Vikram NK, Khanna N. High prevalence
of diabetes,
obesity and
dyslipidaemia in urban slum population in northern
India. Int J Obes Relat Metab Disord 2001;25:1722–9.
- Pais P, Pogue J, Gerstein H, Zachariah E,
Savitha D, Jayprakash S, et al. Risk factors
for acute
myocardial infarction in Indians: A case–control
study. Lancet 1996;348:358–63.
- Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence
of coronary artery disease and its
relationship
to lipids in a selected population in South
India: The
Chennai Urban Population Study (CUPS No. 5). J
Am Coll Cardiol 2001;38:682–7.
- Deepa R, Shanthirani CS, Pradeepa R, Mohan V.
Is the ‘rule of halves’ in hypertension
still valid?—Evidence from the Chennai
Urban Population Study. J Assoc Physicians
India 2003;51:153–7.
- Zachariah MG, Thankappan
KR, Alex SC, Sarma PS, Vasan RS. Prevalence,
correlates, awareness,
treatment,
and control of hypertension in a middle-aged
urban population in Kerala. Indian Heart
J 2003;55:245–51.
- Gupta AK, Ahluwalia SK,
Negi PC, Sood RK, Gupta BP, Dhadwal D. Awareness
of hypertension
among a north
Indian population. J Indian Med Assoc 1998;96:
298–9, 311.
- Chadha SL, Radhakrishnan
S, Ramachandran K, Kaul U, Gopinath N. Prevalence,
awareness
and
treatment status of hypertension in urban population
of Delhi.
Indian J Med Res 1990;92:233–40.
- Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B,
Borch-Johnsen K, et al. Age- and
sex-specific
prevalence
of diabetes and impaired glucose regulation
in 11 Asian cohorts. Diabetes Care 2003;26:1770–80.
- Mohan V, Shanthirani CS, Deepa R. Glucose
intolerance (diabetes and IGT) in a selected
South Indian population
with special reference to family history,
obesity and lifestyle factors—The Chennai
Urban Population Study (CUPS 14). J Assoc Physicians
India 2003;51:771–7.
- Zargar AH, Khan
AK, Masoodi SR, Laway BA, Wani AI, Bashir MI,
et al. Prevalence of type
2 diabetes
mellitus
and impaired glucose tolerance in the Kashmir
valley of the Indian subcontinent. Diabetes
Res Clin Pract 2000;47:135–46.
- Chen Z, Peto R, Collins
R, MacMahon S, Lu J, Li W. Serum cholesterol
concentration and
coronary
heart
disease in population with low cholesterol
concentrations. BMJ 1991;303:276–82.
- Law MR, Wald NJ, Thompson SG. By how much and
how quickly does reduction in serum cholesterol
concentration
lower risk of ischaemic heart disease? BMJ 1994;308:367–72.
- Lewington S, Clarke
R, Qizilbash N, Peto R, Collins R. Prospective
studies collaboration.
Age-specific
relevance of usual blood pressure to vascular
mortality: A meta-analysis of individual data
for one million
adults in 61 prospective studies. Lancet 2002;360:
1903–13.
- MacMahon S, Peto R, Cutler
J, Collins R, Sorlie P, Neaton J, et al. Blood
pressure,
stroke, and
coronary heart disease. Part 1. Prolonged differences
in blood
pressure: Prospective observational studies
corrected for the regression dilution bias.
Lancet 1990;335:765–74.
- Stratton IM,
Adler AI, Neil HAW, Matthews DR, Manley SE,
Cull CA, et al. Association
of glycaemia
with macrovascular
and microvascular complications of type 2 diabetes
(UKPDS 35): Prospective observational study.
BMJ 2000;321:405–12.
- Fuller JH, Shipley
MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease
risk and impaired
glucose
tolerance. The Whitehall study. Lancet 1980;1:1373–6.
- Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell
CJ, Kannel WB, et al. Impact of high-normal
blood pressure on the risk of cardiovascular
disease. N Engl J Med 2001;345:1291–7.
- Lakka HM, Laaksonen
DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto
J, et al. The metabolic
syndrome and
total and cardiovascular disease mortality
in middle-aged
men. JAMA 2002;288:2709–16.
- Lorenzo C,
Okoloise M, Williams K, Stern MP, Haffner SM.
The metabolic syndrome as predictor
of type 2 diabetes:
The San Antonio heart study. Diabetes Care 2003;26:3153–9.
-
Elliott P, Stamler R.
Manual of operations for ‘INTERSALT’,
an international cooperative study
on the relation of sodium and potassium
to blood
pressure. Control Clin Trials 1988;9:1S–117S.
- WHO expert consultation. Appropriate body-mass
index for Asian populations and its implications
for policy
and intervention strategies. Lancet 2004;363:157–63.
-
Steering Committee of the Western Pacific
Region of the World Health Organization,
the
International
Association for the Study of Obesity,
and the International Obesity Task Force.
The Asia-Pacific
perspective: Redefining
obesity and its treatment. Melbourne,
Australia:Health Communications Australia;
2000.
- Han TS, van
Leer EM, Seidell JC, Lean ME. Waist circumference
action levels in the identification
of cardiovascular risk factors: Prevalence
study in a
random sample. BMJ 1995;311:1401–5.
-
Executive Summary of the Third
Report of the National Cholesterol Education
Program (NCEP)
Expert Panel on
Detection, Evaluation, and Treatment
of High
Blood Cholesterol in Adults (Adult
Treatment Panel III).
JAMA 2001;285:2486–97.
-
Alberti KG,
Zimmet PZ. Definition, diagnosis
and classification of diabetes mellitus
and
its complications.
Part 1: Diagnosis and classification
of diabetes mellitus. Provisional report
of a WHO
consultation.
Diabet Med 1998;15:539–53.
-
Lee J, Heng D, Chia
KS, Chew SK, Tan BY, Hughes K. Risk
factors and incident coronary
heart disease
in Chinese, Malay and Asian Indian
males: The Singapore Cardiovascular Cohort
Study.
Int
J Epidemiol 2001;30:983–8.
- Enas EA,
Garg A, Davidson MA, Nair VM, Huet
BA, Yusuf S. Coronary heart disease
and its
risk factors
in first-generation immigrant Asian
Indians to the United States of America. Indian
Heart
J 1996;48:343–53.
- Anand SS, Yusuf S,
Vuksan V, Devanesen S, Teo KK, Montague
PA, et al. Differences
in
risk factors,
atherosclerosis
and cardiovascular disease between
ethnic groups in Canada: The study of health
assessment
and
risk in
ethnic groups (SHARE). Indian Heart
J 2000;52:S35–S43.
- Bhatnagar D, Anand IS, Durrington PN, Patel
DJ, Wander GS, Mackness MI, et al.
Coronary
risk factors
in people from the Indian subcontinent
living in west London and their siblings in India.
Lancet 1995;345:405–9.
- Tao S, Wu X,
Duan X, Fang W, Hao J, Fan D, et al.
Hypertension prevalence and status
of
awareness,
treatment
and control in China. Chin Med J (Engl)
1995;108:483–9.
- Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner
P, et al. Prevalence, awareness,
treatment, and
control of hypertension in China. Hypertension
2002;40:920–7.
- Hypertension Study Group.
Prevalence, awareness, treatment and
control of hypertension
among
the elderly in Bangladesh and India:
A multicentre study. Bull
World Health Organ 2001;79:490–500.
- McKeigue PM, Miller GJ, Marmot MG. Coronary
heart disease in south Asians overseas:
A review. J Clin
Epidemiol 1989;42:597–609.
- Hughes K,
Yeo PP, Lun KC, Thai AC, Sothy SP,
Wang KW, et al. Cardiovascular diseases
in Chinese,
Malays,
and Indians in Singapore. II. Differences
in risk factor levels. J Epidemiol
Community Health
1990;44:29–35.
- Reddy KS, Prabhakaran
D, Shah P, Shah B. Differences in body
mass index and waist:hip
ratios in North
Indian rural and urban populations.
Obes Rev
2002;3:197–202.
- Knowler WC, Barrett-Connor
E, Fowler SE, Hamman RF, Lachin JM, Walker
EA, et al. Diabetes
Prevention
Program Research Group. Reduction in the
incidence of type 2 diabetes with lifestyle
intervention
or metformin. N Engl J Med 2002;346:
393–403.
- Tuomilehto J, Lindstrom J, Eriksson
JG, Valle TT, Hamalainen H, Ilanne-Parikka
P,
et al. Prevention
of
type 2 diabetes mellitus by changes
in lifestyle among subjects with impaired glucose
tolerance.
N Engl J
Med 2001;344:1343–50.
- Park YW, Zhu
S, Palaniappan L, Heshka S, Carnethon
MR, Heymsfield SB. The metabolic
syndrome: Prevalence
and associated risk factor findings in
the US population from the Third National Health
and
Nutrition Examination
Survey, 1988–1994. Arch Intern Med
2003;163:427–36.
|
Cardiothoracic Sciences Centre, All
India Institute of Medical Sciences, Ansari Nagar,
New Delhi 110029, India
D. PRABHAKARAN, LAKSHMY RAMAKRISHNAN,
K. SRINATH REDDY Department of Cardiology
Department of Internal Medicine, Mayo Clinic, Rochester,
USA
PANKAJ SHAH Division of Endocrinology
Initiative for Cardiovascular Health Research in Developing
Countries, New Delhi, India
VIVEK CHATURVEDI
Initiative for Cardiovascular Health Research in Developing
Countries, New Delhi, India and Division of Hospital
Medicine, Hackley Hospital, Muskegon, Michigan, USA
AJAY MANHAPRA
Correspondence to K. SRINATH REDDY; ksreddy@ichealth.org |
|